Has Laura Dellalana, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,389 in general payments to Laura Dellalana, MD across 149 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Laura Dellalana, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Laura Dellalana, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Laura Dellalana, MD

Dermatology · Branford, CTNPI 1114486321

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 149 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 39.2% of the total. 2025 is the largest year on record at $1,532, 7.2 times the $212 reported in 2022. That places this record below the midpoint for dermatology clinicians in CT, where the typical reported total is $3,198.

$3,389in general payments, 2019–2025

Across 149 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Pfizer$703
Regeneron Healthcare Solutions, Inc.$316
Sanofi$227
Johnson & Johnson$193
Novartis$155
plus $465 from 14 others

What the payments were for

Food & beverage$3,31798%
Education$722%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	66	$1,330
Pfizer	29	$703
Regeneron Healthcare Solutions, Inc.	13	$316
Sanofi	9	$227
Johnson & Johnson	6	$193
Novartis	5	$155
Mayne Pharma Commercial LLC	2	$48
Galderma Laboratories, L.p.	2	$47
E.r. Squibb & Sons, L.L.C.	2	$46
LEO Pharma Inc.	2	$43
Almirall LLC	2	$42
Arcutis Biotherapeutics, Inc.	2	$41
Sun Pharmaceutical Industries Inc.	2	$33
Neurocrine Biosciences, Inc.	1	$28
Dermavant Sciences, Inc.	1	$28
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$24
Organon	1	$24
Verrica Pharmaceuticals Inc.	1	$23
Botanix SB Inc	1	$20
Lilly USA, LLC	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LITFULO$106

How this compares

$3,389 in reported general payments places this provider in the 50th percentile of 222 dermatology providers in Connecticut.

See all dermatology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$165,237

Medicare patients

616

Services billed

2,886

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	223	$3,809
Fluorouracil	61	$3,646
Tacrolimus	24	$1,930
Clobetasol Propionate	56	$1,619
Calcipotriene	12	$1,347
Fluocinonide	41	$1,181
Metronidazole	22	$914
Betamethasone Dipropionate	18	$752
Clindamycin Phosphate	30	$747
Hydrocortisone	118	$670
Triamcinolone Acetonide	137	$647
Minoxidil	32	$515
Doxycycline Hyclate	21	$393
Ciclopirox	11	$194
Mupirocin	17	$63

Paid to pharmacies, not to this prescriber.

Other dermatology in Branford

Michael PayetteCromwell$3.2M
Bruce StroberCromwell$2.9M
Brett KingFairfield$2.5M
Mona ShahriariCromwell$2.2M
Jeremy MossMadison$2M
Brittany CraiglowFairfield$1.9M
Meagen McCuskerEnfield$1.8M
Marcus McFerrenOrange$872K
Christopher BunickNew Haven$661K
Keith ChoateNew Haven$362K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →